MedTrace Logo

Pimecrolimus Cream for Oral Lichen Planus

NCT00297037 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2012-10-17

Study results available
· View outcomes & findings →

Summary

Study investigating the use of pimecrolimus 1% cream for oral lichen planus

Conditions

  • Oral Lichen Planus

Interventions

DRUG

Pimecrolimus 1% cream

pimecrolimus cream or matching placebo BID for 6 weeks

Sponsors & Collaborators

Principal Investigators

  • Christopher Hull, MD · University of Utah

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-08-31
Primary Completion
2009-02-28
Completion
2009-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00297037 on ClinicalTrials.gov